Literature DB >> 17959639

ACE mediates ventilator-induced lung injury in rats via angiotensin II but not bradykinin.

R M Wösten-van Asperen1, R Lutter, J J Haitsma, M P Merkus, J B van Woensel, C M van der Loos, S Florquin, B Lachmann, A P Bos.   

Abstract

Ventilator-induced lung injury is characterised by inflammation and apoptosis, but the underlying mechanisms are poorly understood. The present study proposed a role for angiotensin-converting enzyme (ACE) via angiotensin II (Ang II) and/or bradykinin in acute lung injury. The authors assessed whether ACE and, if so, Ang II and/or bradykinin are implicated in inflammation and apoptosis by mechanical ventilation. Rats were ventilated for 4 h with low- or high-pressure amplitudes in the absence or presence of the ACE inhibitor captopril. Nonventilated animals served as controls. ACE activity, Ang II and bradykinin levels, as well as inflammatory parameters (total protein, macrophage inflammatory protein-2 and interleukin-6) were determined. Apoptosis was assessed by the number of activated caspase-3 and TUNEL (terminal deoxynucleotidyltransferase-mediated deoxyuridine triphosphate nick-end labelling)-positive cells. Bronchoalveolar lavage fluid ACE activity, levels of total protein, inflammatory parameters and the number of apoptotic cells were increased in the high-pressure amplitude group as compared with the control group. Blocking ACE activity by captopril attenuated inflammation and apoptosis in the latter group. Similar results were obtained by blocking Ang II receptors, but blocking bradykinin receptors did not attenuate the anti-inflammatory and anti-apoptotic effects of captopril. The current authors conclude that inflammation and apoptosis in ventilator-induced lung injury is, at least in part, due to angiotensin-converting enzyme-mediated angiotensin II production.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17959639     DOI: 10.1183/09031936.00060207

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  17 in total

Review 1.  Emerging therapies for the prevention of acute respiratory distress syndrome.

Authors:  Carl A Ruthman; Emir Festic
Journal:  Ther Adv Respir Dis       Date:  2015-05-22       Impact factor: 4.031

Review 2.  Integrating microRNAs into a system biology approach to acute lung injury.

Authors:  Tong Zhou; Joe G N Garcia; Wei Zhang
Journal:  Transl Res       Date:  2011-02-04       Impact factor: 7.012

3.  Angiotensin converting enzyme versus angiotensin converting enzyme-2 selectivity of MLN-4760 and DX600 in human and murine bone marrow-derived cells.

Authors:  Shrinidh Joshi; Narayanaganesh Balasubramanian; Goutham Vasam; Yagna Pr Jarajapu
Journal:  Eur J Pharmacol       Date:  2016-02-03       Impact factor: 4.432

4.  Surfactant protein A (SP-A) and angiotensin converting enzyme (ACE) as early biomarkers for pulmonary edema formation in ventilated human lung lobes.

Authors:  Mirjam Gnadt; Boris Kardziev; Michael Schmidt; Petra Högger
Journal:  Lung       Date:  2012-04-01       Impact factor: 2.584

5.  Ventilator-induced inflammatory response in lipopolysaccharide-exposed rat lung is mediated by angiotensin-converting enzyme.

Authors:  Roelie M Wösten-van Asperen; René Lutter; Patricia A C Specht; Job B van Woensel; Chris M van der Loos; Sandrine Florquin; Burkhard Lachmann; Albert P Bos
Journal:  Am J Pathol       Date:  2010-03-19       Impact factor: 4.307

Review 6.  Coronavirus pathogenesis.

Authors:  Susan R Weiss; Julian L Leibowitz
Journal:  Adv Virus Res       Date:  2011       Impact factor: 9.937

7.  Body mass index is associated with the development of acute respiratory distress syndrome.

Authors:  M N Gong; E K Bajwa; B T Thompson; D C Christiani
Journal:  Thorax       Date:  2009-09-21       Impact factor: 9.139

Review 8.  Diabetes, insulin, and development of acute lung injury.

Authors:  Shyoko Honiden; Michelle N Gong
Journal:  Crit Care Med       Date:  2009-08       Impact factor: 7.598

9.  Angiotensin II is related to the acute aortic dissection complicated with lung injury through mediating the release of MMP9 from macrophages.

Authors:  Zhiyong Wu; Yongle Ruan; Jinxing Chang; Bowen Li; Wei Ren
Journal:  Am J Transl Res       Date:  2016-03-15       Impact factor: 4.060

Review 10.  A hypothesis for pathobiology and treatment of COVID-19: The centrality of ACE1/ACE2 imbalance.

Authors:  Krishna Sriram; Paul A Insel
Journal:  Br J Pharmacol       Date:  2020-05-22       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.